Immune checkpoint inhibitors for the treatment of gastric cancer
Gastric cancer (GC) is the fifth most incident and the fourth deadliest cancer worldwide. GC is a heterogeneous disease from the histological and molecular standpoints. This malignancy is mostly diagnosed at advanced stages of the disease, where the available therapeutic interventions are not effect...
Main Author: | |
---|---|
Format: | masterThesis |
Language: | eng |
Published: |
2021
|
Subjects: | |
Online Access: | https://hdl.handle.net/10216/134392 |
Country: | Portugal |
Oai: | oai:repositorio-aberto.up.pt:10216/134392 |